| pubmed-article:10762050 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10762050 | lifeskim:mentions | umls-concept:C0033262 | lld:lifeskim |
| pubmed-article:10762050 | lifeskim:mentions | umls-concept:C0031684 | lld:lifeskim |
| pubmed-article:10762050 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
| pubmed-article:10762050 | lifeskim:mentions | umls-concept:C1704259 | lld:lifeskim |
| pubmed-article:10762050 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:10762050 | lifeskim:mentions | umls-concept:C1705987 | lld:lifeskim |
| pubmed-article:10762050 | lifeskim:mentions | umls-concept:C0871161 | lld:lifeskim |
| pubmed-article:10762050 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:10762050 | pubmed:dateCreated | 2000-8-17 | lld:pubmed |
| pubmed-article:10762050 | pubmed:abstractText | Phosphopeptide prodrugs bearing two S-acyl-2-thioethyl (SATE) biolabile phosphate protections were developed. They are capable to inhibit the Shc/Grb2 interaction and MAP kinases (ERK1 and ERK2) phosphorylation in cellular assay. The S-acetyl-2-thioethyl (MeSATE) analogue showed an IC50 of 1 microM in the inhibition of the colony formation of tumor cell line NIH3T3/HER2. | lld:pubmed |
| pubmed-article:10762050 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10762050 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10762050 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10762050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10762050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10762050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10762050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10762050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10762050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10762050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10762050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10762050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10762050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10762050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10762050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10762050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10762050 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10762050 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:10762050 | pubmed:issn | 0960-894X | lld:pubmed |
| pubmed-article:10762050 | pubmed:author | pubmed-author:LinW JWJ | lld:pubmed |
| pubmed-article:10762050 | pubmed:author | pubmed-author:VidalMM | lld:pubmed |
| pubmed-article:10762050 | pubmed:author | pubmed-author:GarbayCC | lld:pubmed |
| pubmed-article:10762050 | pubmed:author | pubmed-author:MathéCC | lld:pubmed |
| pubmed-article:10762050 | pubmed:author | pubmed-author:PérigaudCC | lld:pubmed |
| pubmed-article:10762050 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10762050 | pubmed:day | 3 | lld:pubmed |
| pubmed-article:10762050 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:10762050 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10762050 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10762050 | pubmed:pagination | 669-72 | lld:pubmed |
| pubmed-article:10762050 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:10762050 | pubmed:meshHeading | pubmed-meshheading:10762050... | lld:pubmed |
| pubmed-article:10762050 | pubmed:meshHeading | pubmed-meshheading:10762050... | lld:pubmed |
| pubmed-article:10762050 | pubmed:meshHeading | pubmed-meshheading:10762050... | lld:pubmed |
| pubmed-article:10762050 | pubmed:meshHeading | pubmed-meshheading:10762050... | lld:pubmed |
| pubmed-article:10762050 | pubmed:meshHeading | pubmed-meshheading:10762050... | lld:pubmed |
| pubmed-article:10762050 | pubmed:meshHeading | pubmed-meshheading:10762050... | lld:pubmed |
| pubmed-article:10762050 | pubmed:meshHeading | pubmed-meshheading:10762050... | lld:pubmed |
| pubmed-article:10762050 | pubmed:meshHeading | pubmed-meshheading:10762050... | lld:pubmed |
| pubmed-article:10762050 | pubmed:meshHeading | pubmed-meshheading:10762050... | lld:pubmed |
| pubmed-article:10762050 | pubmed:meshHeading | pubmed-meshheading:10762050... | lld:pubmed |
| pubmed-article:10762050 | pubmed:meshHeading | pubmed-meshheading:10762050... | lld:pubmed |
| pubmed-article:10762050 | pubmed:meshHeading | pubmed-meshheading:10762050... | lld:pubmed |
| pubmed-article:10762050 | pubmed:meshHeading | pubmed-meshheading:10762050... | lld:pubmed |
| pubmed-article:10762050 | pubmed:meshHeading | pubmed-meshheading:10762050... | lld:pubmed |
| pubmed-article:10762050 | pubmed:meshHeading | pubmed-meshheading:10762050... | lld:pubmed |
| pubmed-article:10762050 | pubmed:meshHeading | pubmed-meshheading:10762050... | lld:pubmed |
| pubmed-article:10762050 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10762050 | pubmed:articleTitle | Inhibition of the ras-dependent mitogenic pathway by phosphopeptide prodrugs with antiproliferative properties. | lld:pubmed |
| pubmed-article:10762050 | pubmed:affiliation | Laboratoire de Pharmacochimie Moléculaire et Structurale, U266 INSERM, UMR 8600 CNRS, Faculté de Pharmacie, Paris, France. | lld:pubmed |
| pubmed-article:10762050 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10762050 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:10762050 | lld:chembl |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10762050 | lld:pubmed |
